{"artifact":{"id":"paper-fig-paper-41782198-2","artifact_type":"paper_figure","entity_ids":"[]","title":"Figure 2. — Safety and efficacy of ravulizumab in patients with NMOSD previously treated wit","quality_score":0.5,"created_by":"paper_figures_tool","provenance_chain":"[{\"step\": \"paper_figures_backfill\", \"pmid\": \"paper-41782198\", \"timestamp\": \"2026-04-22T01:29:42.325758\"}]","content_hash":null,"metadata":{"pmid":"paper-41782198","caption":"Kaplan-Meier curve for time to first TESAE of infections and infestations in RTX-exposed vs RTX-Naïve patients. Kaplan-Meier estimates were calculated to evaluate the time to first TESAE of infections and infestations in patients treated with ravulizumab, stratified by prior RTX exposure. Patients who did not experience a TESAE of infections and infestations were censored at the earliest date of study completion, discontinuation date, last assessment date, death date, and data cutoff date. RTX, rituximab; TESAE, treatment-emergent serious adverse event.","image_url":"https://www.ebi.ac.uk/europepmc/articles/PMC13036264/bin/10.1177_13524585261425076-fig2.jpg","paper_title":"Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.","figure_label":"Figure 2.","figure_number":2,"_schema_version":1,"source_strategy":"pmc_api"},"created_at":"2026-04-21T18:29:40.747630-07:00","updated_at":"2026-04-21T18:29:40.747630-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"external","origin_url":null,"lifecycle_changed_at":"2026-04-21T18:29:40.747630-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"2321b2d9-fc68-42c4-b557-0f4ae86749f7","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"paper_figures_tool"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"paper-41782198","link_type":"cites","strength":0.9,"evidence":"paper_figure.metadata.pmid=paper-41782198"}],"incoming_links":[],"current_artifact_id":"paper-fig-paper-41782198-2","is_canonical":true,"supersede_chain":["paper-fig-paper-41782198-2"]}